Quantitative Aspects of Thyroid Scintigraphy With Pertechnetate (99mTcO4) in Cats

Thyroidal ^99mTcO₄(pertechnetate) uptake percentages were determined in unanesthetized euthyroid (n = 13) and hyperthyroid (n = 18) cats. Maximal uptakes were observed 60 minutes after IV injection of the radionuclide and ranged from 0.3 to 3.9% of the dose in euthyroid cats (median 2.23%) and from 5.2% to 23.9% of the dose in hyperthyroid cats (median 14.8%) ( P < .05). There were no overlaps in pertechnetate uptake percentages during any of the intervals evaluated. It is concluded that the optimal time for visualization of the thyroid by ^99mTcO₄-scanning is 60 minutes after IV injection of the radionuclide. Calculation of the percentage uptake is of additional diagnostic value.     

Thrombocytopenia in Cats: A Retrospective Study of 41 Cases

The prevalence of feline thrombocytopenia (<200,000 platelets/L) at North Carolina State University, College of Veterinary Medicine Teaching Hospital, from January 1985 to March 1990, was 1.2% (41/3300). Cats were divided into six categories based on clinical diagnoses: 29% (12/41) had infectious disease, 20% (8/41) had neoplasia, 7% (3/41) had cardiac disease, 2% (1/41) had primary immune-mediated disease, 22% (9/41) had multiple diseases, and 20% (8/41) had disorders of unknown etiology. The mean platelet count for all thrombocytopenic cats was 52,000/μL ± 46,000/μL (1 SD) with a range of 1000–190,000/μL. No significant differences were found between groups with respect to platelet count, packed cell volume, or white blood cell count, though anemia and leukopenia were common among the cats as a whole. Bleeding disorders (hemorrhage or thrombosis) were observed in 29% (12/41) of thrombocytopenic cats and were more likely to be associated with neoplasia, cardiac disease, and platelet counts less than or equal to 30,000/μL. Disseminated intravascular coagulopathy was diagnosed in 12% (5/41) of the cats. Infections and/or neoplasia affecting the bone marrow were the most common diseases associated with thrombocytopenia. Feline leukemia virus and myeloproliferative neoplasia accounted for approximately 44% (18/41) of the specific diagnoses in thrombocytopenic cats. (Journal of Veterinary Internal Medicine 1993; 7:261–265. Copyright © 1993 by the American College of Veterinary Internal Medicine.)     

In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondrial defect model

The uptake and distribution of intramuscularly (IM) administered tritium-labeled polysulfated glycosaminoglycan (³H-PSGAG) in serum, synovial fluid, and articular cartilage of eight horses was quantitated, and hyaluronic acid (HA) concentration of the middle carpal joint was evaluated in a pharmacokinetic study. A full-thickness articular cartilage defect, created on the distal articular surface of the left radial carpal bone of each horse served as an osteochondral defect model. ³H-PSGAG (500 mg) was injected IM, between 14 and 35 days after creation of the defects. Scintillation analysis of serum and synovial fluid, collected from both middle carpal joints at specific predetermined times up to 96 hours post-injection, revealed mean ³H-PSGAG concentrations peaked at 2 hours post-injection. ³H-PSGAG was detected in cartilage and subchondral bone 96 hours post-injection in samples from all eight horses. There were no statistically significant differences in ³H-PSGAG concentration of synovial fluid or cartilage between cartilage defect and control (right middle carpal) joints.

HA assay of synovial fluid revealed concentrations significantly increased at 24, 48, and 96 hours post-injection in both joints. The concentration nearly doubled 48 hours post-injection. However, no statistically significant differences were found between synovial concentrations of HA in cartilage defect and control joints.

³H-PSGAG administered IM to horses, was distributed in the blood, synovial fluid, and articular cartilage. HA concentrations in synovial fluid increased after IM administration of polysulfated glycosaminoglycan.     

Coagulopathic Effects and Therapy of Brodifacoum Toxicosis in Dogs

The clinical signs and laboratory changes of brodifacoum (BDF) intoxicated dogs and their response to vitamin K1 treatment were examined. Brodifacoum, a second-generation anticoagulant rodenticide, was fed to four dogs for 3 consecutive days producing a cumulative dose of 1.1 mg BDF/kg body weight. Clinical observations of the animals were made daily throughout the study. Monitored laboratory parameters included: one-stage prothrombin time (OSPT), activated partial thromboplastin time (APTT), activated coagulation time (ACT), complete blood counts, thrombocyte counts, and serum chemistry values. Response to vitamin K1 therapy was evaluated clinically and by laboratory tests. Serum BDF concentrations were monitored. Inappetence and hemorrhagic tendencies were exhibited by day 5 postrodenticide exposure. One-stage prothrombin time, APTT, and ACT were 25% greater than time zero values at 24, 24, and 72 hours postdosing, respectively. All laboratory parameters returned to normal within 48 hours of initiating vitamin K1 therapy (0.83 mg/kg orally, TID for 5 days). Serum brodifacoum concentrations were highest (1065-1215 ng/mL) during the 3 days after BDF dosing and were detectable (3.0-7.5 ng/mL) until day 24 postexposure. A mean BDF elimination half-life of 6 +/- 4 days was observed.     

Variation of the growth hormone gene in ryr 1 genotyped Austrian pig breeds

SUMMARY: Polymorphism in the second intron of the porcine growth hormone gene of 273 Austrian Landrace and 81 Austrian Edelschwein pigs was investigated with a PCR-RFLP-technique. Results showed significantly different genotype patterns between the two breeds. The frequency of the Hae II(-) allele was significantly (P < 0,001) higher in the landrace than in the Edelschwein population (0,83 and 0,47 resp.). The Msp I(+) allele was predominant in both breeds but signifanctly higher in the Landrace (0,98 versus 0,69; P < 0,01). Analyses the Hae II/Msp I locus combination revealed also in breed specific difference. In the Landrace a very low interaction was found between the Hae II and ryr 1 locus, and between Msp I and ryr 1 locus (c. c. = 0,181 and 0,186 resp.). The correlation was slightly stronger (c. c. = 0,266) between the ryr 1 and Hae II/Msp I genotypes. No correlation was detected among the three loci in the Edelschwein population. ZUSAMMENFASSUNG: Variabilit?t des Somatotropin Gens in ?sterreichischen Schweinerassen genotypisiert hinsicbtlich ryr 1 An 273 ?sterreichischen Landrasse Schweinen und 81 ?sterreichischen Edelschweinen wurde der Polymorphismus am zweiten Intron des Schweinewachstumshormons mittels PCR-RFLP-Technik untersucht. Genotypen-und Genfrequenzen waren zwischen den beiden Rassen signifikant verschie- den. Die Hae II(-) Allelfrequenz war bei den Landrassetieren signifikant h?her (P < 0,001) als bei den Edelschweinen (0,83 bzw. 0,47). In beiden Rassen überwiegte das Msp I(+) Allel, das aber signifikant ?fters bei der Landrasse auftrat (0,98 bzw. 0,69; P < 0,01). Die Verteilung der Locuskombination von Hae II/Msp I zwischen den beiden Rassen war ebenfalls unterschiedlich. Bei der Landrasse konnte nur ein sehr geringer Zusammenhang zwischen dem Hae II und ryr 1 Locus (c. c. = 0,181 bzw. 0,186) und auch zwischen dem Msp I und ryr 1 Locus festgestellt werden. Die Korrelation zwischen dem ryr 1 und Hae II/Msp I Genotyp war geringfügig gr??;er (c. c. = 0,266). Bei den Edelschweinen konnte kein Zusammenhang zwischen den drei untersuchten Loci festgestellt werden.